13D/13G Filings - Cormorant Asset Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-07-07
4:01 pm
Purchase
2022-06-27 13G Altimmune, Inc.
ALT
Cormorant Asset Management LP 3,000,000
6.130%
3,000,000increase
(New Position)
Filing
History
2022-06-17
4:30 pm
Purchase
2021-12-31 13G VectivBio Holding AG
VECT
Cormorant Asset Management LP 2,840,389
6.160%
2,840,389increase
(New Position)
Filing
History
2022-06-06
5:50 pm
Purchase
2022-06-03 13G Prometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP 2,224,847
5.680%
376,825increase
(+20.39%)
Filing
2022-02-14
3:18 pm
Purchase
2022-02-02 13G GreenLight Biosciences Holdings
GRNA
Cormorant Asset Management LP 9,479,058
7.720%
9,479,058increase
(New Position)
Filing
History
2022-02-14
3:17 pm
Purchase
2021-12-31 13G Tango Therapeutics, Inc.
TNGX
Cormorant Asset Management LP 4,899,184
5.600%
4,899,184increase
(New Position)
Filing
History
2022-02-14
3:16 pm
Purchase
2021-12-31 13G Longboard Pharmaceuticals, Inc.
LBPH
Cormorant Asset Management LP 1,381,932
9.990%
42,301increase
(+3.16%)
Filing
History
2022-02-14
3:15 pm
Sale
2021-12-31 13G Prometheus Biosciences, Inc.
RXDX
Cormorant Asset Management LP 1,848,022
4.750%
-250,000decrease
(-11.92%)
Filing
2022-02-14
3:14 pm
Sale
2021-12-31 13G Galecto, Inc.
GLTO
Cormorant Asset Management LP 40,810
4.040%
-45,220decrease
(-52.56%)
Filing
History
2022-02-14
3:13 pm
Purchase
2021-12-31 13G Forma Therapeutics Holdings, Inc.
FMTX
Cormorant Asset Management LP 4,639,998
9.790%
179,998increase
(+4.04%)
Filing
History
2022-02-14
3:12 pm
Sale
2021-12-31 13G Cabaletta Bio, Inc.
CABA
Cormorant Asset Management LP 1,154,424
4.070%
-750,000decrease
(-39.38%)
Filing
History
2022-02-14
3:11 pm
Sale
2021-12-31 13G C4 Therapeutics, Inc.
CCCC
Cormorant Asset Management LP 0
0.000%
-2,490,065decrease
(Position Closed)
Filing
History
2022-02-14
3:10 pm
Sale
2021-12-31 13G Aerovate Therapeutics, Inc.
AVTE
Cormorant Asset Management LP 1,830,691
7.500%
-200,000decrease
(-9.85%)
Filing
History
2022-02-14
3:10 pm
Sale
2021-12-31 13G Revolution Medicines, Inc.
RVMD
Cormorant Asset Management LP 2,431,852
3.300%
-1,243,148decrease
(-33.83%)
Filing
History
2022-02-14
3:09 pm
Sale
2021-12-31 13G Ambrx Biopharma Inc.
AMAM
Cormorant Asset Management LP 17,266,144
7.060%
-138,558decrease
(-0.80%)
Filing
History
2022-02-14
3:08 pm
Sale
2021-12-31 13G Monte Rosa Therapeutics, Inc.
GLUE
Cormorant Asset Management LP 3,002,200
6.460%
-191,774decrease
(-6.00%)
Filing
History
2022-02-14
3:08 pm
Purchase
2021-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,440,451
9.770%
325,607increase
(+6.37%)
Filing
History
2022-02-14
3:07 pm
Sale
2021-12-31 13G BioAtla, Inc.
BCAB
Cormorant Asset Management LP 2,038,215
5.770%
-253,845decrease
(-11.07%)
Filing
History
2022-02-14
3:06 pm
Sale
2021-12-31 13G Avidity Biosciences, Inc.
RNA
Cormorant Asset Management LP 2,012,115
4.290%
-452,432decrease
(-18.36%)
Filing
History
2022-02-14
3:05 pm
Sale
2021-12-31 13G Atea Pharmaceuticals, Inc.
AVIR
Cormorant Asset Management LP 1,679,442
2.020%
-4,731,913decrease
(-73.81%)
Filing
History
2022-02-14
3:04 pm
Purchase
2021-12-31 13G Viridian Therapeutics, Inc.
VRDN
Cormorant Asset Management LP 1,436,322
6.280%
1,436,322increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next